Regulated information
In accordance with the requirements of Article 14 of the Belgian Law of May 2, 2007 on the disclosure of significant shareholdings in listed companies, Ontex Group NV (“Ontex”) discloses the notifications of significant shareholding by the Goldman Sachs Group, Inc.
On August 31, 2026, Ontex received a transparency declaration confirming that, on August 25, 2026, the Goldman Sachs Group, Inc., detained 378,740 Ontex voting rights and 2,592,208 equivalent financial instruments or 2,970,948 combined, representing respectively 0.46%, 3.15 % and 3.61% of Ontex’s issued shares. The number of equivalent financial instruments and the combined holding thereby crossed upward the threshold of 3%.
On September 1, 2026, Ontex received a transparency declaration confirming that, on August 27, 2026, the Goldman Sachs Group, Inc., detained 153,363 Ontex voting rights and 2,349,159 equivalent financial instruments or 2,502,522 combined, representing respectively 0.19%, 2.85% and 3.04% of Ontex’s issued shares. The number of equivalent financial instruments thereby crossed downward the threshold of 3%
Enquiries
| Investors | Geoffroy Raskin | +32 53 333 730 | [email protected] |
| Media | Catherine Weyne | +32 53 333 622 | [email protected] |
About Ontex
Ontex is a leading international developer and producer of baby care, feminine care and adult care products, both for retailers and healthcare, primarily in Europe and North America. The group employs around 5,000 people, with plants and offices in 12 countries, and its innovative products are distributed in around 100 countries. Ontex is headquartered in Aalst, Belgium and is listed on Euronext Brussel. To keep up with the latest news, visit ontex.com or follow Ontex on LinkedIn.
ONTEX Group NV
Korte Keppestraat 21 – 9320 Erembodegem (Aalst) – Belgium 0550.880.915 RPR Ghent – Division Dendermonde
Attachment
- 260903_TD_GoldmanSachs_EN
